US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 2.130
  • +0.030+1.43%
Close Apr 26 16:00 ET
  • 2.130
  • 0.0000.00%
Post 16:00 ET
56.22MMarket Cap-2393P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-53.50%-11.37M
31.42%-2.68M
-111.06%-3.09M
-542.58%-3.52M
-39.95%-2.09M
-366.13%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
-246.23%-547.07K
-461.02%-1.49M
Net income from continuing operations
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
-649.04%-1.56M
-31.02%-1.33M
Depreciation and amortization
156.11%5.47K
443.46%3.08K
143.99%1.38K
32.11%506
-18.55%505
-13.49%2.14K
-8.71%566
-8.71%566
-38.23%383
1.97%620
Change In working capital
746.75%1.65M
525.41%1.42M
467.25%518.55K
-140.61%-365.3K
133.10%75.61K
149.92%195.21K
45.05%-334.75K
-152.31%-141.2K
904.49%899.62K
-61.65%-228.47K
-Change in receivables
-277.94%-893.4K
-664.45%-465.93K
-1,199.60%-380.24K
122.64%24.95K
-100.75%-72.19K
-342.03%-236.38K
-135.73%-60.95K
-37.41%-29.26K
-321.59%-110.22K
-41.06%-35.96K
-Change in prepaid assets
116.18%111.84K
215.26%1.04M
104.40%446.83K
-487.45%-1.33M
87.84%-43.01K
-37.44%-691.05K
-79.77%-898.59K
2,403.27%218.6K
5,365.42%342.68K
-120,830.72%-353.74K
-Change in payables and accrued expense
116.85%2.43M
36.72%854.22K
236.73%451.96K
40.52%937.49K
18.34%190.81K
7,865.92%1.12M
323.23%624.79K
-209.93%-330.54K
509.65%667.16K
238.83%161.23K
Cash from discontinued investing activities
Operating cash flow
-53.50%-11.37M
31.42%-2.68M
-111.06%-3.09M
-542.58%-3.52M
-39.95%-2.09M
-366.13%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
-246.23%-547.07K
-461.02%-1.49M
Investing cash flow
Cash flow from continuing investing activities
-52.09K
-13.18K
0
0
Net PPE purchase and sale
---52.09K
---13.18K
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---52.09K
---13.18K
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
378.44%15.46M
38.28%586.69K
10.07M
4,527.64%4.69M
-95.92%118.92K
-82.85%3.23M
-97.73%424.28K
0
-228.71%-105.96K
4,382.69%2.91M
Net issuance payments of debt
--0
--0
--0
----
----
-125.00%-50K
--0
--0
----
----
Net common stock issuance
377.24%15.7M
35.52%584.07K
--10.13M
8,511.77%4.71M
-90.43%278.92K
-82.36%3.29M
-97.69%431K
--0
---55.96K
--2.91M
Proceeds from stock option exercised by employees
--2.62K
----
----
----
----
--0
----
----
----
----
Net other financing activities
-3,389.23%-234.62K
--1
---58.8K
---15.82K
---160K
---6.72K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
378.44%15.46M
38.28%586.69K
--10.07M
4,527.64%4.69M
-95.92%118.92K
-82.85%3.23M
-97.73%424.28K
--0
-228.71%-105.96K
4,382.69%2.91M
Net cash flow
Beginning cash position
-23.85%13.44M
15.76%19.58M
-31.24%12.65M
-39.86%11.46M
-23.85%13.44M
4,411.66%17.64M
44,423.02%16.92M
16,538.50%18.4M
10,442.71%19.06M
4,411.66%17.64M
Current changes in cash
196.74%4.04M
39.54%-2.1M
574.58%6.94M
280.13%1.18M
-239.05%-1.97M
-124.20%-4.18M
-119.76%-3.48M
-2,016.24%-1.46M
-762.87%-653.03K
801.58%1.42M
Effect of exchange rate changes
204.97%33.09K
20,028.66%31.29K
49.57%-11.77K
366.53%14.14K
79.35%-562
-480.23%-31.52K
-125.28%-157
-567.27%-23.34K
-196.66%-5.3K
66.16%-2.72K
End cash Position
30.31%17.51M
30.31%17.51M
15.76%19.58M
-31.24%12.65M
-39.86%11.46M
-23.85%13.44M
-23.85%13.44M
44,423.02%16.92M
16,538.50%18.4M
10,442.71%19.06M
Free cash flow
-54.20%-11.42M
31.08%-2.69M
-113.72%-3.13M
-542.58%-3.52M
-39.95%-2.09M
-365.90%-7.41M
-250.41%-3.9M
-2,781.24%-1.46M
-246.23%-547.07K
-459.34%-1.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -53.50%-11.37M31.42%-2.68M-111.06%-3.09M-542.58%-3.52M-39.95%-2.09M-366.13%-7.41M-250.41%-3.9M-2,781.24%-1.46M-246.23%-547.07K-461.02%-1.49M
Net income from continuing operations -89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M-649.04%-1.56M-31.02%-1.33M
Depreciation and amortization 156.11%5.47K443.46%3.08K143.99%1.38K32.11%506-18.55%505-13.49%2.14K-8.71%566-8.71%566-38.23%3831.97%620
Change In working capital 746.75%1.65M525.41%1.42M467.25%518.55K-140.61%-365.3K133.10%75.61K149.92%195.21K45.05%-334.75K-152.31%-141.2K904.49%899.62K-61.65%-228.47K
-Change in receivables -277.94%-893.4K-664.45%-465.93K-1,199.60%-380.24K122.64%24.95K-100.75%-72.19K-342.03%-236.38K-135.73%-60.95K-37.41%-29.26K-321.59%-110.22K-41.06%-35.96K
-Change in prepaid assets 116.18%111.84K215.26%1.04M104.40%446.83K-487.45%-1.33M87.84%-43.01K-37.44%-691.05K-79.77%-898.59K2,403.27%218.6K5,365.42%342.68K-120,830.72%-353.74K
-Change in payables and accrued expense 116.85%2.43M36.72%854.22K236.73%451.96K40.52%937.49K18.34%190.81K7,865.92%1.12M323.23%624.79K-209.93%-330.54K509.65%667.16K238.83%161.23K
Cash from discontinued investing activities
Operating cash flow -53.50%-11.37M31.42%-2.68M-111.06%-3.09M-542.58%-3.52M-39.95%-2.09M-366.13%-7.41M-250.41%-3.9M-2,781.24%-1.46M-246.23%-547.07K-461.02%-1.49M
Investing cash flow
Cash flow from continuing investing activities -52.09K-13.18K00
Net PPE purchase and sale ---52.09K---13.18K--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---52.09K---13.18K--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 378.44%15.46M38.28%586.69K10.07M4,527.64%4.69M-95.92%118.92K-82.85%3.23M-97.73%424.28K0-228.71%-105.96K4,382.69%2.91M
Net issuance payments of debt --0--0--0---------125.00%-50K--0--0--------
Net common stock issuance 377.24%15.7M35.52%584.07K--10.13M8,511.77%4.71M-90.43%278.92K-82.36%3.29M-97.69%431K--0---55.96K--2.91M
Proceeds from stock option exercised by employees --2.62K------------------0----------------
Net other financing activities -3,389.23%-234.62K--1---58.8K---15.82K---160K---6.72K----------------
Cash from discontinued financing activities
Financing cash flow 378.44%15.46M38.28%586.69K--10.07M4,527.64%4.69M-95.92%118.92K-82.85%3.23M-97.73%424.28K--0-228.71%-105.96K4,382.69%2.91M
Net cash flow
Beginning cash position -23.85%13.44M15.76%19.58M-31.24%12.65M-39.86%11.46M-23.85%13.44M4,411.66%17.64M44,423.02%16.92M16,538.50%18.4M10,442.71%19.06M4,411.66%17.64M
Current changes in cash 196.74%4.04M39.54%-2.1M574.58%6.94M280.13%1.18M-239.05%-1.97M-124.20%-4.18M-119.76%-3.48M-2,016.24%-1.46M-762.87%-653.03K801.58%1.42M
Effect of exchange rate changes 204.97%33.09K20,028.66%31.29K49.57%-11.77K366.53%14.14K79.35%-562-480.23%-31.52K-125.28%-157-567.27%-23.34K-196.66%-5.3K66.16%-2.72K
End cash Position 30.31%17.51M30.31%17.51M15.76%19.58M-31.24%12.65M-39.86%11.46M-23.85%13.44M-23.85%13.44M44,423.02%16.92M16,538.50%18.4M10,442.71%19.06M
Free cash flow -54.20%-11.42M31.08%-2.69M-113.72%-3.13M-542.58%-3.52M-39.95%-2.09M-365.90%-7.41M-250.41%-3.9M-2,781.24%-1.46M-246.23%-547.07K-459.34%-1.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg